Bioventix PLC (AIM:BVXP)
2,025.00
-25.00 (-1.22%)
Nov 4, 2026, 4:54 PM GMT
Bioventix Balance Sheet
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 5.26 | 5.08 | 6 | 5.72 | 6.13 |
Cash & Short-Term Investments | 5.26 | 5.08 | 6 | 5.72 | 6.13 |
Cash Growth | 3.65% | -15.33% | 4.95% | -6.71% | -5.67% |
Accounts Receivable | 1.43 | 1.03 | 1.52 | 1.17 | 0.75 |
Other Receivables | 0.03 | 0.03 | 0.03 | 0 | 0.01 |
Receivables | 1.45 | 1.06 | 1.55 | 1.17 | 0.76 |
Inventory | 0.71 | 0.69 | 0.62 | 0.57 | 0.46 |
Prepaid Expenses | 4.53 | 5.18 | 4.66 | 4.64 | 4.46 |
Total Current Assets | 11.97 | 12.03 | 12.83 | 12.1 | 11.81 |
Property, Plant & Equipment | 0.43 | 0.4 | 0.48 | 0.58 | 0.69 |
Long-Term Investments | 0.43 | 0.43 | 0.43 | 0.61 | 0.61 |
Total Assets | 12.83 | 12.86 | 13.73 | 13.28 | 13.12 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.27 | 0.08 | 0.17 | 0.08 | 0.16 |
Accrued Expenses | 0.43 | 0.4 | 0.4 | 0.41 | 0.39 |
Current Portion of Leases | 0 | - | - | - | - |
Current Income Taxes Payable | 0.7 | 0.84 | 1.15 | 0.71 | 0.71 |
Total Current Liabilities | 1.4 | 1.31 | 1.73 | 1.2 | 1.25 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.02 | 0.04 |
Other Long-Term Liabilities | 0.01 | - | - | - | - |
Total Liabilities | 1.41 | 1.31 | 1.73 | 1.22 | 1.3 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 |
Additional Paid-In Capital | 1.54 | 1.54 | 1.47 | 1.47 | 1.33 |
Retained Earnings | 9.61 | 9.75 | 10.27 | 10.33 | 10.23 |
Comprehensive Income & Other | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity | 11.42 | 11.55 | 12 | 12.06 | 11.82 |
Total Liabilities & Equity | 12.83 | 12.86 | 13.73 | 13.28 | 13.12 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0 | - | - | - | - |
Net Cash (Debt) | 5.26 | 5.08 | 6 | 5.72 | 6.13 |
Net Cash Growth | 3.57% | -15.33% | 4.95% | -6.71% | -5.67% |
Net Cash Per Share | 0.99 | 0.96 | 1.13 | 1.08 | 1.16 |
Filing Date Shares Outstanding | 5.22 | 5.22 | 5.22 | 5.22 | 5.21 |
Total Common Shares Outstanding | 5.22 | 5.22 | 5.22 | 5.22 | 5.21 |
Working Capital | 10.57 | 10.72 | 11.1 | 10.9 | 10.56 |
Book Value Per Share | 2.18 | 2.21 | 2.30 | 2.31 | 2.27 |
Tangible Book Value | 11.42 | 11.55 | 12 | 12.06 | 11.82 |
Tangible Book Value Per Share | 2.18 | 2.21 | 2.30 | 2.31 | 2.27 |
Machinery | 1.01 | 0.95 | 0.96 | 0.94 | 0.93 |